Management of Trigeminal Neuralgia with Carbamazepine and Transcutaneous Electrical Nerve Stimulation.

Comparative efficacy of carbamazepine therapy with and without transcutaneous electrical nerve stimulation therapy for the management of trigeminal neuralgia: A Randomized Controlled Trial. - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/07/070214

Enrollment

Registered

2024-07-08

Start date

Unknown

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G500- Trigeminal neuralgia

Interventions

Intervention1: Carbamazepine Therapy and Transcutaneous Electrical Nerve Stimulation: Patient of age range of 20–80 years who are primarily diagnosed as Trigeminal Neuralgia. Patient will be treated w

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals with a clinical diagnosis of idiopathic or classical TN. 2. Individuals who had never had treatment before. 3. Individuals who had not received TN treatment over the previous six months.

Exclusion criteria

Exclusion criteria: Individuals with compromised health,Pregnant women, People with hypertension, Individuals who wear pacemakers.

Design outcomes

Primary

Measure	Time frame
1The severity of pain may be reduced, which will be evaluated using a VAS score. 2Duration of pain episodes measured in minutes may be reduced. 3Frequency (Number of pain episodes) per day may be reduced.Timepoint: at baseline, 1 months, and 3 months	—

Secondary

Measure	Time frame
NILTimepoint: NA	—

Countries

India

Contacts

Public ContactDr Vidya Lohe

Datta Meghe Institute of Higher Education and Research

vidyalohekadu@gmail.com9960445040

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026